HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
  Home
Seattle Children's Chief AI Officer talks better outcomes through the technology
AI/ML

Seattle Children's Chief AI Officer talks better outcomes through the technology

9:20

Dr. Zafar Chaudry says AI is a component that allows users to now look at things in a different way and provide better care.

Read More
Read Less

AI/ML - Similar Videos View more in AI/ML

5:21

At Delaware Valley, AI projects are scaling steadily

The community health system is moving beyond early wins with revenue cycle and operations, and is now looking at clinical applications such as ambient listening, agentic AI and robotic process automation, says CIO Isaiah Nathaniel.

At Delaware Valley, AI projects are scaling steadily
The community health system is moving beyond early wins with revenue cycle and operations, and is now looking at clinical applications such as ambient listening, agentic AI and robotic process automation, says CIO Isaiah Nathaniel.
5:21
16:28

AI, data and the future of Middle Eastern medicine

Fakeeh Care Group's Dr. Tamara Sunbul discusses a future for healthcare in which AI "copilots" support clinicians, data flows freely through systems and patients are more empowered, resulting in more preventive and proactive care.

AI, data and the future of Middle Eastern medicine
Fakeeh Care Group's Dr. Tamara Sunbul discusses a future for healthcare in which AI "copilots" support clinicians, data flows freely through systems and patients are more empowered, resulting in more preventive and proactive care.
16:28
10:54

Redefining aging as a treatable condition

Alex Aliper, Insilico Medicine's president, says that longevity progress is already being made, but that regulators need to classify aging as a disease and track its biomarkers to enable more therapeutic advances.

Redefining aging as a treatable condition
Alex Aliper, Insilico Medicine's president, says that longevity progress is already being made, but that regulators need to classify aging as a disease and track its biomarkers to enable more therapeutic advances.
10:54